Loading chat...
US HR848
Resolution
Status
10/31/2025
Primary Sponsor
Thomas Kean
Click for details
AI Summary
-
Affirms continued U.S. Government support for purchasing vaccines for low-income countries through Gavi, the Vaccine Alliance, as a cost-effective means to reduce child and maternal mortality
-
Recognizes Gavi's impact since 2000: immunization of over 1.1 billion children across 78 countries, an estimated 18.8 million deaths averted, and 70% reduction in childhood deaths from vaccine-preventable diseases
-
Supports Gavi's goals including scaling up routine immunizations, improving program sustainability, ensuring healthy vaccine markets, and strengthening health systems for equitable immunization access
-
Encourages multiyear U.S. pledges to maximize Gavi's impact and leverage contributions from other donors, noting $54 in health and economic savings returned for every $1 invested
-
Calls for increased U.S. commitment to Gavi during the 2026-2030 strategic period, which includes plans to provide 50 million malaria vaccine doses to children in supported countries
Legislative Description
Supporting the role of the United States in helping save the lives of children and protecting the health of people in low-income countries with vaccines and immunization through Gavi, the Vaccine Alliance ("Gavi").
International affairs
Last Action
Referred to the House Committee on Foreign Affairs.
10/31/2025